Cheol-Kyu Park

Featured in: Favicon

onlinelibrary.wiley.com

Articles

Cancers | Free Full-Text | Real-World Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-Based Doublet Chemotherapy and Immunotherapy (SPACE Study)

Nov 24, 2023 | mdpi.com | Wonjun Ji |In-Jae Oh |Cheol-Kyu Park |Sung Lee

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial

Apr 25, 2023 | mdpi.com | Cheol-Kyu Park |Hyung-Joo Oh |Ji-Young Lee |Hyun-Ju Cho

This is an early access version, the complete PDF, HTML, and XML versions will be available soon.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →